Acetyl-L-lysine
| Code | Size | Price |
|---|
| TAR-T4856-100mg | 100mg | £94.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
Acetyl-L-lysine is a N-acetylated amino acid. It is a normal constituent of human urine with concentrations in normal samples too small to allow its routine detection; however, it has been found at increased levels in the urine of a patient with aminoacylase I deficiency.
CAS:
1946-82-3
Molecular Weight:
188.22
Pathway:
Metabolism
Purity:
0.998
SMILES:
CC(=O)N[C@@H](CCCCN)C(O)=O
Target:
Endogenous Metabolite
References
Brown D G , Rao S , Weir T L , et al. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool[J]. Cancer & Metabolism, 2016, 4(1):11.
Goedert J J , Sampson J N , Moore S C , et al. Fecal metabolomics: assay performance and association with colorectal cancer[J]. Carcinogenesis, 2014, 35(9):2089-2096.
Van Coster R N, Gerlo EAGiardina T G, Engelke U F, et al. Aminoacylase I deficiency: a novel inborn error of metabolism[J]. Biochemical & Biophysical Research Communications, 2005, 338(3):1322-1326.
Sinha R , Ahn J , Sampson J N , et al. Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations[J]. PLOS ONE, 2016, 11(3):e20152126.